{
    "2019-06-19": [
        [
            {
                "time": "2019-06-19",
                "original_text": "Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Takeover",
                        "Motivation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "GSK kicks off sale of $1.2 billion consumer health drugs: sources",
                "features": {
                    "keywords": [
                        "GSK",
                        "sale",
                        "consumer health drugs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal",
                "features": {
                    "keywords": [
                        "Cancer",
                        "Gene Therapy",
                        "Biotechs",
                        "Pfizer-Array Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company",
                "features": {
                    "keywords": [
                        "Stock Charts",
                        "Pfizer",
                        "FMC",
                        "McCormick"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "industrial",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "Big Drugmakers That May Tread the M&A Path After Pfizer",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "M&A",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "2 Midcaps to Watch Should Pfizer-Array Deal Spark M&A Fever in Biotech Land",
                "features": {
                    "keywords": [
                        "Midcaps",
                        "Pfizer-Array Deal",
                        "M&A",
                        "Biotech"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "Health Care Sector Update for 06/19/2019: MLNT, CALA, MYOS, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update",
                        "MLNT",
                        "CALA",
                        "MYOS",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-19",
                "original_text": "A Beloved Biotech ETF Could Lure Traders Again",
                "features": {
                    "keywords": [
                        "Biotech ETF",
                        "Traders"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "ETFs"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}